The significance of Ki-67 proliferative index and cyclin D1 expression of dysplastic nevi in the biologic spectrum of melanocytic lesions
- PMID: 17525627
- DOI: 10.1097/01.pai.0000209868.58699.64
The significance of Ki-67 proliferative index and cyclin D1 expression of dysplastic nevi in the biologic spectrum of melanocytic lesions
Abstract
Familial acquired dysplastic nevi carry a risk for the development of melanoma. However, the results in various studies regarding the significance of sporadic dysplastic nevi as a precursor of malignant melanoma (MM), are controversial. The aim of this study is to investigate cyclin D1 expression and Ki67 proliferative index in a group of melanocytic lesions to address the biologic significance of sporadic dysplastic nevi in the progression of melanocytic lesions. Formalin-fixed paraffin-embedded material from 21 common melanocytic nevi, 42 dysplastic nevi, and 17 primary cutaneous MMs were examined. Standard streptavidin-biotin immunoperoxidase method was used for immunostaining with cyclin D1 and Ki-67 antibody. Nuclear cyclin D1 immunostaining was scored and Ki-67 proliferative index was calculated. Cyclin D1 expression was significantly higher in melanoma than those in other lesions. However, there was no significant difference between dysplastic nevi and common melanocytic nevi in terms of cyclin D1 expression. Ki-67 index was significantly higher in dysplastic nevi compared with common melanocytic nevi and to melanoma compared with dysplastic nevi. There was a significant positive correlation between cyclin D1 expression and Ki-67 proliferative index for each group. The present study indicates significant differences in cyclin D1 expressions and Ki-67 indices among melanocytic lesions. We think that dysplastic nevi are biologically separate from common melanocytic nevi in terms of proliferative activity. Additionally, our results suggest that cyclin D1 expression may be related to malignant phenotype and is associated with high proliferation rate in MM.
Similar articles
-
Cyclin D1 and D3 expression in melanocytic skin lesions.Arch Dermatol Res. 2010 Sep;302(7):545-50. doi: 10.1007/s00403-010-1054-3. Epub 2010 May 23. Arch Dermatol Res. 2010. PMID: 20496072 Free PMC article.
-
IMP-3 EXPRESSION IN BENIGN MELANOCYTIC NEVI, DYSPLASTIC NEVI AND MALIGNANT MELANOMA: PRELIMINARY FINDINGS IN BULGARIAN PATIENTS.J Biol Regul Homeost Agents. 2015 Jul-Sep;29(3):695-9. J Biol Regul Homeost Agents. 2015. PMID: 26403409
-
Cyclin D1 expression in melanocytic lesions of the skin.Ann Diagn Pathol. 2005 Aug;9(4):185-8. doi: 10.1016/j.anndiagpath.2005.04.018. Ann Diagn Pathol. 2005. PMID: 16084449
-
[Dysplastic melanocytic nevus].Duodecim. 2010;126(21):2492-501. Duodecim. 2010. PMID: 21171474 Review. Finnish.
-
The histopathology of dysplastic nevi. Continued controversy.Am J Dermatopathol. 1991 Feb;13(1):38-51. doi: 10.1097/00000372-199102000-00008. Am J Dermatopathol. 1991. PMID: 2003647 Review.
Cited by
-
Protective Effect of Genistein on Cyclin D1 Expression in Malignant Ocular Melanoma Cells.Med Arch. 2021 Jun;75(3):180-183. doi: 10.5455/medarh.2021.75.180-183. Med Arch. 2021. PMID: 34483446 Free PMC article.
-
Protective effects of carvacrol and pomegranate against methotrexate-induced intestinal damage in rats.Int J Clin Exp Med. 2015 Sep 15;8(9):15474-81. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26629037 Free PMC article.
-
Prognostic and Clinicopathological Significance of CCND1/Cyclin D1 Upregulation in Melanomas: A Systematic Review and Comprehensive Meta-Analysis.Cancers (Basel). 2021 Mar 15;13(6):1314. doi: 10.3390/cancers13061314. Cancers (Basel). 2021. PMID: 33804108 Free PMC article. Review.
-
The dysplastic nevus: from historical perspective to management in the modern era: part II. Molecular aspects and clinical management.J Am Acad Dermatol. 2012 Jul;67(1):19.e1-12; quiz 31-2. doi: 10.1016/j.jaad.2012.03.013. J Am Acad Dermatol. 2012. PMID: 22703916 Free PMC article.
-
Hesperidin Attenuates Hypothyroidism-Induced Lung Damage in Adult Albino Rats by Modulating Oxidative Stress, Nuclear Factor Kappa-B Pathway, Proliferating Cell Nuclear Antigen and Inflammatory Cytokines.Biomedicines. 2023 May 29;11(6):1570. doi: 10.3390/biomedicines11061570. Biomedicines. 2023. PMID: 37371665 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous